Trials / Completed
CompletedNCT04972682
[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer
Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer: a Prospective Open-label Single-arm Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- Moscow City Oncology Hospital No. 62 · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
While total hysterectomy without lymph node staging is standard for low- and intermediate-risk endometrial cancer, certain histopathologic factors can necessitate additional interventions. Our study assesses the influence of sentinel lymph node (SLN) biopsy on postoperative decision-making.
Conditions
- Endometrial Cancer
- Endometrial Neoplasms
- Endometrial Adenocarcinoma
- Endometrial Cancer Stage I
- Endometrial Cancer Stage II
- Endometrial Endometrioid Adenocarcinoma
- Sentinel Lymph Node
- Hysterectomy
- Laparoscopic Hysterectomy
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laparoscopic total hysterectomy with bilateral salpingo-oophorectomy and sentinel lymph node biopsy | Laparoscopic total hysterectomy, bilateral salpingo-oophorectomy (BSO), and sentinel lymph node (SLN) biopsy are executed by 1 of 5 experienced gynecologic oncologists. SLN mapping utilizes indocyanine green (ICG) at a standard concentration of 2.5 mg/mL - 1 mL is injected into the cervix at the 3 and 9 o'clock positions (total dose - 5 mg) to a depth of 5-10 mm, initiated right after general anesthesia induction. Diagnostic laparoscopy employs the Image 1S equipment (KARL STORZ©, Tuttlingen, Germany). Upon examination, fluorescence in the near-infrared spectrum is observed. Successful mapping is indicated by identifying a lymphatic vessel with at least one LN. Detected SLNs are then extracted, and the total hysterectomy with BSO is completed. SLN frozen section remains at the surgeon's discretion. If metastasis surfaces in the SLN either during the frozen section or routine assessment, the option for systematic LN dissection in a subsequent procedure exists although not mandatory. |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2023-08-15
- Completion
- 2024-04-15
- First posted
- 2021-07-22
- Last updated
- 2024-05-07
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT04972682. Inclusion in this directory is not an endorsement.